MMCAP International’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

MMCAP International’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-451,172	Closed	-$4.53M	–	204
2023 Q4	$4.53M	Buy	+451,172	New	+$2.05M	0.83%	17

MMCAP International's GRCL Position: Q1 2024 in Review

MMCAP International sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 451,172 shares — an estimated $4.53M sold.

MMCAP International first reported a position in GRCL in Q4 2023 and held it in 1 quarter. The position peaked at $4.53M in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

MMCAP International reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
MMCAP International sold 451,172 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $4.53M.
MMCAP International first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2023 and held it in 1 quarter.
MMCAP International's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $4.53M in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on MMCAP International's 13F filing for Q1 2024, filed 9 May 2024.